Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Capital Expenditures (2016 - 2026)

Phibro Animal Health has reported Capital Expenditures over the past 13 years, most recently at $11.1 million for Q4 2025.

  • For Q4 2025, Capital Expenditures rose 41.87% year-over-year to $11.1 million; the TTM value through Dec 2025 reached $45.8 million, up 3324.91%, while the annual FY2025 figure was $38.3 million, 1517.79% up from the prior year.
  • Capital Expenditures for Q4 2025 was $11.1 million at Phibro Animal Health, down from $13.8 million in the prior quarter.
  • Over five years, Capital Expenditures peaked at $23.2 million in Q3 2022 and troughed at -$38.1 million in Q2 2023.
  • A 5-year average of $4.3 million and a median of $7.9 million in 2023 define the central range for Capital Expenditures.
  • On a YoY basis, Capital Expenditures climbed as much as 211.13% in 2022 and fell as far as 412.95% in 2022.
  • Year by year, Capital Expenditures stood at $7.7 million in 2021, then increased by 27.69% to $9.8 million in 2022, then rose by 11.61% to $11.0 million in 2023, then decreased by 28.62% to $7.8 million in 2024, then soared by 41.87% to $11.1 million in 2025.
  • Business Quant data shows Capital Expenditures for PAHC at $11.1 million in Q4 2025, $13.8 million in Q3 2025, and $13.1 million in Q2 2025.